The Use Of Dosing Software With Bayesian Forecasting To Improve Antimicrobial-plasma Concentrations In The Intensive Care Unit
Funder
National Health and Medical Research Council
Funding Amount
$77,422.00
Summary
Emerging technologies such as DSBF is capable of assisting clinicians with selecting dosing regimens that achieve the target antimicrobial concentrations needed for treating infections. We will conduct a clinical trial to investigate the ability of DSBF to improve antimicrobial concentrations of patients in the ICU. The results of this study may lead to clinicians being given a new powerful validated tool for improving the treatment outcomes of patients suffering from infections in the ICU.
A Prospective, Randomised, Double-blind Trial Of Extended- Versus Bolus-infusion ?-lactam Therapy In Infective Exacerbations Of Cystic Fibrosis
Funder
National Health and Medical Research Council
Funding Amount
$148,431.00
Summary
I am an infectious diseases physician focused on the most effective way to use antibiotics to treat infections. People with cystic fibrosis often get lung infections and the bacteria that causes this, Pseudomonas aeruginosa, can be difficult to treat. I will be investigating whether infusing antibiotics over a prolonged period of time is more effective than standard therapy in treatment of Pseudomonas aeruginosa lung infections in patients with cystic fibrosis.
A Prospective Study Of The Aetiology, Associations, Clinical Features And Outcomes Of Community-acquired Pneumonia In Children And Adults In Tropical Australia
Funder
National Health and Medical Research Council
Funding Amount
$106,937.00
Summary
Pneumonia is common in Australia and often requires hospital admission. The germs that cause pneumonia in tropical Australia are less well known than southern Australia and likely to be different. This study will identify which germs cause pneumonia in people in tropical Australia and will identify which people become more unwell. I aim to identify the best antibiotics to use, the differences between children and adults, Indigenous and non-Indigenous people and people living in different areas.
Improving Dosing Of Common Antibiotics Used In Critically Ill Australian Indigenous Patients
Funder
National Health and Medical Research Council
Funding Amount
$98,148.00
Summary
Optimal antibiotic dosing in patients in the intensive care unit saves lives. However, the way antibiotics move through the body of an intensive care unit patient can be different to other patients. Therefore, research that identifies specific dosing for these patients is essential. Further to this, no research in an Indigenous population is available. The aim of this research is to address this gap by developing optimal antibiotic doses for Indigenous Australians in the intensive care unit.